captopril

Poland

Drugs containing this active substance

  • CAPTOPRIL JELFA

    The medicine is used in the treatment of arterial hypertension, chronic heart failure, myocardial infarction, and nephropathy (kidney disease) occurring in type I diabetes.

    Form: tablets

    Active substance Dosage
    captopril 12.5 mg

    ATC: C09AA01

    Manufacturer: Jelfa Pharmaceutical Enterprise S.A.

  • The medicinal product is used in the treatment of arterial hypertension, chronic heart failure, myocardial infarction, and nephropathy (kidney disease) occurring in type I diabetes.

    Form: tablets

    Active substance Dosage
    captopril 25 mg

    ATC: C09AA01

    Manufacturer: Jelfa Pharmaceutical Enterprise S.A.

  • The medicine is used to treat arterial hypertension, chronic heart failure, myocardial infarction, and nephropathy (kidney disease) occurring in type I diabetes.

    Form: tablets

    Active substance Dosage
    captopril 50 mg

    ATC: C09AA01

    Manufacturer: Jelfa Pharmaceutical Enterprise S.A.

  • The medicine is used to treat arterial hypertension, chronic heart failure, diabetic nephropathy, and in patients following a myocardial infarction with left ventricular dysfunction.

    Form: tablets

    Active substance Dosage
    captopril 25 mg

    ATC: C09AA01

    Manufacturer: Polfarmex S.A.

  • The medicine is intended for the treatment of arterial hypertension, chronic heart failure, diabetic nephropathy, and asymptomatic left ventricular dysfunction following myocardial infarction.

    Form: tablets

    Active substance Dosage
    captopril 50 mg

    ATC: C09AA01

    Manufacturer: Polfarmex S.A.

  • The medicine is used to treat arterial hypertension, chronic heart failure, diabetic nephropathy, and in patients following a myocardial infarction with left ventricular dysfunction.

    Form: tablets

    Active substance Dosage
    captopril 12.5 mg

    ATC: C09AA01

    Manufacturer: Polfarmex S.A.